|Videos|October 27, 2020

Educated Patient® Leukemia and Lymphoma Summit: October 27, 2020

View the entire CURE® Educated Patient® Leukemia & Lymphoma Summit. A virtual event seeking to educate, inform and challenge the thinking of patients with leukemia and lymphoma.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!

Related Content

Cancer in the Rearview Mirror

ByJohn Smelcer, PhD, CAGS

December 15th 2025

Most premenopausal women with early breast cancer accepted GnRHa during chemotherapy to preserve ovarian function; cryopreservation uptake was lower: © stock.adobe.com.

Fertility Decisions Influenced by Age and Parental Status in Premenopausal Breast Cancer

ByRyan Scott

December 12th 2025

Inluriyo and Verzenio helped patients with ER+/HER2– advanced breast cancer stay on treatment longer without their disease worsening vs standard therapy.

Inluriyo/Verzenio Extends Treatment Benefit in ER+/HER2– Breast Cancer

ByJason Broderick

December 12th 2025

HRT Use Does Not Raise Breast Cancer Risk in BRCA Carriers

ByPaige Britt

December 12th 2025

Electronic Intervention Improves Quality of Life in Younger Breast Cancer Survivors

ByAlex Biese

December 12th 2025

Educated Patient® Leukemia and Lymphoma Summit: October 27, 2020

Newsletter

Related Content

Cancer in the Rearview Mirror

Fertility Decisions Influenced by Age and Parental Status in Premenopausal Breast Cancer

Inluriyo/Verzenio Extends Treatment Benefit in ER+/HER2– Breast Cancer

HRT Use Does Not Raise Breast Cancer Risk in BRCA Carriers

Electronic Intervention Improves Quality of Life in Younger Breast Cancer Survivors

Trending on CURE

FDA Approves Enhertu Plus Perjeta in Advanced HER2+ Breast Cancer

Light the Night and Survivorship: The Importance of Remembrance

FDA Approves Akeega Combo in BRCA2+ Metastatic Prostate Cancer

Accepting That You Are Changed by Cancer

FDA Grants Breakthrough Designation to INCA-33989 in Essential Thrombocythemia